Peter Greenleaf - Jan 27, 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)

Role
Director
Signature
/s/ Peter Greenleaf
Stock symbol
BDSI
Transactions as of
Jan 27, 2022
Transactions value $
$418,510
Form type
4
Date filed
1/31/2022, 05:02 PM
Previous filing
Aug 10, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +10.2K +10.81% $0.00 105K Jan 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Stock Options (right to buy) Award $419K +114K $3.66 114K Jan 27, 2022 Common Stock 114K $3.66 Direct F2, F3
transaction BDSI Restricted Stock Units Award $0 +20.5K $0.00 20.5K Jan 27, 2022 Common Stock 20.5K $0.00 Direct F1
transaction BDSI Restricted Stock Units Options Exercise $0 -10.2K -50% $0.00 10.2K Jan 27, 2022 Common Stock 10.2K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units ("RSUs") were issued to the Reporting Person as compensation for service on the Company's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan ("the Plan"). The RSUs vest in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.
F2 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
F3 The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.